Urgently needed: A funding mechanism to insulate cancer research from political whims

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.

April 10, 2026

Vol.52 No.14

By Claire Marie Porter and Paul Goldberg

Guest Editorial

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

Recently, a friend lent me a copy of a decades-old report, and by old, I mean a classic.

April 10, 2026

Vol.52 No.14

By Robert A. Winn

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Cancer AI Alliance announces first wave of pilot projects

Cancer AI Alliance announced its first wave of eight pilot projects across a federated learning platform. These projects represent the first wave of the organization’s efforts and aim to demonstrate that it is possible to analyze vast amounts of data while keeping patient privacy secure at the local level.

April 10, 2026

Vol.52 No.14

Cancer Policy

NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH

Budgets can surprise you, and the White House budget proposal for fiscal year 2027 is more surprising than most.

April 03, 2026

Vol.52 No.13

By Paul Goldberg

Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.

March 27, 2026

Vol.52 No.12

By Richard M. Goldberg

Urgently needed: A funding mechanism to insulate cancer research from political whims

YOU MAY BE INTERESTED IN

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

Cancer AI Alliance announces first wave of pilot projects

NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

Renew today!

Subscriber content

Never miss an issue!

Login

Urgently needed: A funding mechanism to insulate cancer research from political whims

YOU MAY BE INTERESTED IN

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdyNCI expects record-breaking spending on extramural research

America needs a new blueprint for the National Cancer ProgramFirst step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantageCancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

Cancer AI Alliance announces first wave of pilot projects

NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH

In the era of immunotherapy, response rate alone fails to predict true patient benefitRegulators must adapt

Never miss an issue!

Login

Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt